COMMUNIQUÉS West-GlobeNewswire

Philips Foundation publishes 2018 Annual Report
01/07/2019
July 1, 2019 Amsterdam, the Netherlands – The Philips Foundation , established by Royal Philips (NYSE: PHG; AEX: PHIA) as the central platform for Philips’ CSR activities, today announced publication of its 2018 Annual [...]
Announcement no. 06/2019 - The French Ministry of Health has announced a price reform within Ostomy Care, Continence Care and Wound Care
01/07/2019
Following a reimbursement review the French Ministry of Health has published new final classifications and prices within Ostomy Care, Continence Care and Wound Care in France. The new classifications and prices will be [...]
Herantis Pharma publishes newsletter for May-June
01/07/2019
Herantis Pharma publishes newsletter for May-June Herantis Pharma Plc Press release 1 July 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for May-June 2019. The newsletter is also attached [...]
Nanobiotix announces new organizational structure as the company enters its next stage after first european market approval
01/07/2019
NANOBIOTIX ANNOUNCES NEW ORGANIZATIONAL STRUCTURE AS THE COMPANY ENTERS ITS NEXT STAGE AFTER FIRST EUROPEAN MARKET APPROVAL Recently appointed Chief Medical Officer (CMO) Edwina Baskin-Bey, M.D., will join the Executive [...]
Nanobiotix annonce une nouvelle équipe de direction à la suite de son autorisation de mise sur le marché européen
01/07/2019
NANOBIOTIX ANNONCE UNE NOUVELLE ÉQUIPE DE DIRECTION À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCHÉ EUROPÉEN Récemment nommée Directeur Médical (CMO), le Dr Edwina Baskin-Bey rejoint le Directoire Anne-Juliette [...]
Oxurion NV Reports Positive Topline Phase 1 Results with THR-149, a novel, potent plasma kallikrein inhibitor for the treatment
01/07/2019
Topline data show that THR-149 is well-tolerated and safe. No dose-limiting toxicities or drug-related serious adverse events reported. Rapid onset of action starting at Day 1 with increasing average improvement in Best [...]
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE.
01/07/2019
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE. CryoSave chose PBKM as the appropriate subcontractor for the secured long [...]
ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
01/07/2019
ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE. CryoSave a choisi PBKM comme sous-traitant approprié pour le stockage sécurisé [...]
Basilea extends phase 2 study with derazantinib in intrahepatic bile duct cancer (iCCA) to include patients with FGFR2 gene mutations or amplifications
01/07/2019
Basel, Switzerland, July 01, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the first patient was enrolled in a newly opened cohort in the ongoing FIDES-01 phase 2 registrational study with the [...]
Genkyotex’s GKT831 Prevents Multiple Complications of Portal Hypertension in Preclinical Model
01/07/2019
Data Supports Therapeutic Role of GKT831 in Advanced Liver Fibrosis Results published in Clinics and Research in Hepatology and Gastroenterology Phase 3 trial being planned in primary biliary cholangitis ARCHAMPS, [...]
Le GKT831 de Genkyotex prévient de multiples complications de l’hypertension portale dans un modèle préclinique
01/07/2019
Les données confirment le rôle thérapeutique du GKT831 dans la fibrose avancée du foie Résultats publiés dans Clinics and Research in Hepatology and Gastroenterology Un essai de Phase 3 est envisagé dans la cholangite [...]
ASIT Biotech Continues its Transformation From Research to Late Stage Clinical Development
01/07/2019
Company shareholders approve all motions at Extraordinary General Meeting Firm expects to raise €9-12 M to finance focused development Jean-Paul Prieels confirmed as new member of Board of Directors Phase III on track [...]
ObsEva appoints industry expert as Chief Medical Officer to further advance its Phase 3 clinical programs
01/07/2019
Geneva, Switzerland and Boston, MA – July 1, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Inspirotec advances “Exhale” product business expansion
01/07/2019
CHICAGO, June 30, 2019 (GLOBE NEWSWIRE) -- Inspirotec Inc., is a rapidly growing Chicago-based company with it’s Exhale™ highly portable whole house allergen measuring system and remediation support services. Exhale™ is [...]
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
30/06/2019
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business. CEO, Frédéric Amar, has converted part of his loan [...]
Atara Biotherapeutics Presents Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)
29/06/2019
SOUTH SAN FRANCISCO, Calif., June 29, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Biogen announces European label update for SPINRAZA (nusinersen) which includes longer-term data across a broad range of ages and types of Spinal Muscular Atrophy
29/06/2019
Label update includes data from four clinical studies including long-term safety and efficacy data across a broad Spinal Muscular Atrophy (SMA) population Data from over 300 patients across a broad range of ages and [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/06/2019
CAMBRIDGE, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 28, 2019, that were previously [...]
MedMira Reports Third Quarter Results
29/06/2019
HALIFAX, Nova Scotia, June 28, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2019. Q3 FY2019 Financial Results Highlights Profit and [...]

Pages